136 related articles for article (PubMed ID: 1974673)
1. Beta-agonistic properties of tulobuterol, a new beta-sympathicomimetic drug, and its effects on pulmonary beta-adrenoceptor characteristics.
Terpstra GK; Raaijmakers JA
Lung; 1990; 168 Suppl():179-85. PubMed ID: 1974673
[TBL] [Abstract][Full Text] [Related]
2. A comparison between clenbuterol, salbutamol and terbutaline in relation to receptor binding and in vitro relaxation of equine tracheal muscle.
Törneke K; Ingvast Larsson C; Appelgren LE
J Vet Pharmacol Ther; 1998 Oct; 21(5):388-92. PubMed ID: 9811440
[TBL] [Abstract][Full Text] [Related]
3. Beta-2 adrenergic responses to tulobuterol in airway smooth muscle, vascular smooth muscle and adrenergic nerves.
Ruff F; Zander JF; Edoute Y; Santais MC; Flavahan NA; Verbeuren TJ; Vanhoutte PM
J Pharmacol Exp Ther; 1988 Jan; 244(1):173-80. PubMed ID: 2826765
[TBL] [Abstract][Full Text] [Related]
4. Relevance of changes in adrenoceptor characteristics after terbutaline treatment.
Terpstra GK; Wassink GA; Raaijmakers JA
Ann Allergy; 1983 Feb; 50(2):121-5. PubMed ID: 6297336
[TBL] [Abstract][Full Text] [Related]
5. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function.
Kume H; Kondo M; Ito Y; Suzuki R; Yamaki K; Takagi K
Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1076-83. PubMed ID: 12390295
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue.
Hauck RW; Harth M; Schulz C; Präuer H; Böhm M; Schömig A
Br J Pharmacol; 1997 Aug; 121(8):1523-30. PubMed ID: 9283684
[TBL] [Abstract][Full Text] [Related]
7. Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis.
Patel KR
Lung; 1990; 168 Suppl():210-8. PubMed ID: 1974679
[TBL] [Abstract][Full Text] [Related]
8. Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease.
Werdermann K
Lung; 1990; 168 Suppl():202-9. PubMed ID: 1974678
[TBL] [Abstract][Full Text] [Related]
9. Tulobuterol: a full beta-adrenoceptor agonist or a partial beta-agonist with membrane stabilizing activity?
Gonzalez-Sicilia L; Perez-Ojeda E; Laorden ML; Brugger AJ; Hernandez J
Gen Pharmacol; 1988; 19(1):103-6. PubMed ID: 2894330
[TBL] [Abstract][Full Text] [Related]
10. Desensitization to beta-receptor mediated bronchodilator drugs in the rat: decreased beta-receptor affinity.
Avner BP; Noland B
Proc West Pharmacol Soc; 1978; 21():175-81. PubMed ID: 29302
[No Abstract] [Full Text] [Related]
11. Can a new beta 2-agonist reduce the mortality of asthma?
Aldons PM
Lung; 1990; 168 Suppl():186-91. PubMed ID: 1974675
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
Chong LK; Suvarna K; Chess-Williams R; Peachell PT
Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
[TBL] [Abstract][Full Text] [Related]
13. The involvement of ATP-sensitive potassium channels in beta-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed.
Randall MD; McCulloch AI
Br J Pharmacol; 1995 Jun; 115(4):607-12. PubMed ID: 7582479
[TBL] [Abstract][Full Text] [Related]
14. In vivo desensitization to beta receptor mediated bronchodilator drugs in the rat: decreased beta receptor affinity.
Avner BP; Noland B
J Pharmacol Exp Ther; 1978 Oct; 207(1):23-33. PubMed ID: 29962
[TBL] [Abstract][Full Text] [Related]
15. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
Landi M; Bianchetti A; Croci T; Manara L
Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
[TBL] [Abstract][Full Text] [Related]
16. The effect of tulobuterol tape on histamine-induced bronchoconstriction in conscious guinea pigs: long duration of action.
Musoh K; Kawamura K; Miyake I; Shimada S; Ohashi T; Iwanaga Y; Morikawa K; Kato H
Jpn J Pharmacol; 1999 Mar; 79(3):401-2. PubMed ID: 10230871
[TBL] [Abstract][Full Text] [Related]
17. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
Gan LL; Wang MW; Cheng MS; Pan L
Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
[TBL] [Abstract][Full Text] [Related]
18. Characterization of putative beta-adrenoceptors in the myometrium of the pregnant ewe: correlation between the binding of [3H] dihydroalprenolol and the inhibition of myometrial contractility in vitro.
Crankshaw DJ; Ruzycky AL
Biol Reprod; 1984 Apr; 30(3):609-18. PubMed ID: 6144332
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies of 1-(2-chloro-4-hydroxyphenyl)-2-t-butylaminoethanol (HOKU-81), a new bronchodilator. 1st Communication: Bronchodilator and cardiovascular actions.
Kubo S; Matsubara I; Yamazaki M; Kasamatsu S; Koshinaka E; Kato H; Kase Y
Arzneimittelforschung; 1980; 30(8):1272-8. PubMed ID: 7192141
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological effects mediated by the stimulation of cardiac beta 2-adrenoceptors with tulobuterol.
Mugelli A; Amerini S; De Bonfioli Cavalcabo P; Cerbai E; Visentin S
Cardiovasc Drugs Ther; 1987; 1(1):101-7. PubMed ID: 2908698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
